Human Germline Manipuation and Cloning as Women's Issues
By Marcy Darnovsky,
GeneWatch
| 06. 30. 2001
While the prospect of genetically "redesigned" people challenges humanity as a whole, it particularly threatens groups that historically have been disempowered. And because human germline engineering and cloning are so closely tied to reproduction, they are of special concern to women.
The New Eugenics and the Commercialization of Reproduction
Already, prenatal screening and preimplantation diagnosis make it possible to eliminate fetuses and embryos with a number of identifiable genetic conditions. As disability rights activists point out, these developments put women in the position of "eugenic gatekeepers." Inheritable genetic modification, to whatever extent it turns out to be technically possible, would amplify the powers of eugenic selection many times over.
If a new "free-market eugenics" were to take hold, who would actually exercise "consumer preference" for genetic "enhancements?" Who would decide what was on offer?
Human cloning and germline engineering would move decisions about reproduction further away from women, not only toward doctors and technicians but also toward marketers proffering the "enhancements" developed by biotech companies. Women could find themselves simultaneously losing ever more control of their own childbearing experiences, and...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...